BiPar Sciences Company
BiPar Sciences is a pharmacological company developing PARP inhibitors as cancer therapies.
Total Funding:
$74 965 000
Technology:
Medical Devices
Last Funding Type:
Series C
Founded Date:
2002
Industry:
Women Cancer Treatment
Employee Number:
11-50
Funding Status:
M&A
Headquarters:
Brisbane, California, United States